27.09.2014 Views

Program - Society of Toxicology

Program - Society of Toxicology

Program - Society of Toxicology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2011<br />

<strong>Program</strong> Description (Continued)<br />

Abstract #<br />

#406 Poster Board Number.....................................827<br />

E7 VIRAL ONCOPROTEIN NEGATIVELY<br />

INFLUENCES THE TRANSCRIPTIONAL<br />

ACTIVITY OF THE L1MD<br />

RETROTRANSPOSON PROMOTER UNDER<br />

CONDITIONS OF CELLULAR STRESS. ​<br />

D. E. Montoya-Durango 1,2 and K. S. Ramos 1,2 .<br />

1<br />

Biochemistry and Molecular Biology, University <strong>of</strong><br />

Louisville, Louisville, KY and 2 Center for Genetics<br />

and Molecular Medicine, University <strong>of</strong> Louisville,<br />

Louisville, KY.<br />

#407 Poster Board Number.....................................828<br />

NEOPLASTIC LUNG CELL<br />

PROLIFERATION, STIMULATED BY<br />

ALVEOLAR MACROPHAGE-DERIVED<br />

IGF-1, CAN BE ABROGATED BY THE<br />

COMBINED INHIBITION OF MEK AND<br />

PI3K. ​J. M. Fritz, L. D. Dwyer-Nield and A. M.<br />

Malkinson. Department <strong>of</strong> Pharmaceutical Sciences,<br />

University <strong>of</strong> Colorado Denver, Aurora, CO.<br />

#408 Poster Board Number.....................................829<br />

MASS SPECTROMETRY TECHNIQUES TO<br />

STUDY PROTEIN-LIGAND INTERACTIONS<br />

AND MOLECULAR TOXICOLOGY<br />

PATHWAYS. ​K. E. Yamada 1,2 , C. M. Ryan 3 , J.<br />

P. Whitelegge 3 and C. D. Eckhert 1,2 . 1 Molecular<br />

<strong>Toxicology</strong> IDP, University <strong>of</strong> California Los<br />

Angeles, Los Angeles, CA, 2 Environmental Health<br />

Sciences, University <strong>of</strong> California Los Angeles, Los<br />

Angeles, CA and 3 The Pasarow Mass Spectrometry<br />

Laboratory, The NPI-Semel Institute, David Geffen<br />

School <strong>of</strong> Medicine, University <strong>of</strong> California Los<br />

Angeles, Los Angeles, CA.<br />

#409 Poster Board Number.....................................830<br />

DICLOFENAC INHIBITS TNF-INDUCED<br />

NF-B NUCLEAR SHUTTLING CAUSING<br />

SYNERGISTIC HEPATOCYTE APOPTOSIS<br />

VIA CASPASE-8. ​L. Fredriksson, B. Herpers, Z.<br />

Di and B. van de Water. <strong>Toxicology</strong>, LACDR, Leiden<br />

University, Leiden, Netherlands.<br />

#410 Poster Board Number.....................................831<br />

NRF2B: A NOVEL NRF2 PARALOG IN<br />

ZEBRAFISH. ​A. R. Timme-Laragy 1 , S. I.<br />

Karchner 1 , D. G. Franks 1 , M. J. Jenny 2 and M.<br />

E. Hahn 1 . 1 Biology, Woods Hole Oceanographic<br />

Institution, Woods Hole, MA and 2 University <strong>of</strong><br />

Alabama, Tuscaloosa, AL.<br />

#411 Poster Board Number.....................................832<br />

CRITICAL CYSTEINE RESIDUES OF<br />

KEAP1 IN SUPPRESSION OF NRF2 BASAL<br />

ACTIVITY AND ARSENIC-SENSING BY<br />

REGULATING THE UBIQUITINATION-<br />

PROTEASOMAL DEGRADATION OF NRF2<br />

PROTEIN. ​X. He 1 and Q. Ma 1,2 . 1 Receptor Biology<br />

Lab. /TMBB/HELD, NIOSH, Morgantown, WV and<br />

2<br />

Biochemistry, West Virginia University, School <strong>of</strong><br />

Medicine, Morgantown, WV.<br />

Abstract #<br />

#412 Poster Board Number.....................................833<br />

THE KEAP1-NRF2 SYSTEM REGULATES<br />

METALLOTHIONEIN EXPRESSION AND<br />

PROTECTS VASCULAR ENDOTHELIAL<br />

CELLS FROM CADMIUM CYTOTOXICITY. ​<br />

Y. Shinkai 1 , Y. Kumagai 1 , T. Kimura 2 , C. Yamamoto 3 ,<br />

M. Yamamoto 4 , H. Jinno 5 , T. Tanaka-Kagawa 5 and T.<br />

Kaji 6 . 1 Graduate School <strong>of</strong> Comprehensive Human<br />

Sciences, University <strong>of</strong> Tsukuba, Tsukuba, Japan,<br />

2<br />

Faculty <strong>of</strong> Pharmaceutical Sciences, Setsunan<br />

University, Osaka, Japan, 3 Faculty <strong>of</strong> Pharmaceutical<br />

Sciences, Hokuriku University, Kanazawa, Japan,<br />

4<br />

Graduate School <strong>of</strong> Medicine, Tohoku University,<br />

Sendai, Japan, 5 Division <strong>of</strong> Environmental<br />

Chemistry, National Institute <strong>of</strong> Health Sciences,<br />

Tokyo, Japan and 6 Faculty <strong>of</strong> Pharmaceutical<br />

Sciences, Tokyo University <strong>of</strong> Science, Noda, Japan.<br />

Sponsor: A. Naganuma.<br />

#413 Poster Board Number.....................................834<br />

MECHANISTIC INVOLVEMENT OF THE<br />

NRF2/KEAP1 ANTI-OXIDANT RESPONSE<br />

IN THE REGULATION OF HUMAN ABCC3. ​<br />

M. D. Merrell 1 , M. J. Canet 1 , F. Zhao 1 , T. Wu 1 , J.<br />

M. Maher 2 and N. J. Cherrington 1 . 1 Pharmacology<br />

and <strong>Toxicology</strong>, University <strong>of</strong> Arizona, Tucson, AZ<br />

and 2 Department <strong>of</strong> Medical Biochemistry, Tohoku<br />

University, Sendai, Japan.<br />

#414 Poster Board Number.....................................835<br />

ATTENUATION OF THE NRF2 SIGNALING<br />

PATHWAY IN HEPATOCYTES LACKING<br />

SIRTUIN 1 (SIRT1). ​W. Wei 1 , J. Xu 1 , S. Kulkarni 1 ,<br />

X. Li 2 and A. Slitt 1 . 1 BPS, University <strong>of</strong> Rhode<br />

Island, Kingston, RI and 2 National Institute <strong>of</strong><br />

Environmental Health Sciences, Research Triangle<br />

Park, NC.<br />

#415 Poster Board Number.....................................836<br />

RESPONSE OF NRF2-MODULATED GENES<br />

TO CIGARETTE SMOKE. ​B. Kosmider, E.<br />

Messier, H. Chu and R. J. Mason. National Jewish<br />

Health, Denver, CO.<br />

#416 Poster Board Number.....................................837<br />

INDIRUBIN-3’-(2, 3 DIHYDROXYPROPYL)-<br />

OXIMETHER (E804) IS A POTENT<br />

AHR-AGONIST AND MODULATOR OF<br />

INFLAMMATION PROFILES IN LPS-<br />

TREATED RAW264.7 MACROPHAGES. ​A.<br />

S. Babcock and C. D. Rice. Biological Sciences,<br />

Clemson University, Clemson, SC.<br />

Monday Morning, March 7<br />

10:30 AM to 11:30 AM<br />

Room 156<br />

Exhibitor Hosted Session: First in Human Monoclonal<br />

Antibody Development Strategies for the Treatment <strong>of</strong><br />

Cancer Patients<br />

Presented by: Huntingdon Life Sciences<br />

Monoclonal antibodies have demonstrated to provide huge healthcare<br />

benefits in treatment <strong>of</strong> cancer. Designing and performing the optimal IND<br />

enabling nonclinical safety package is very important. Some non-standard<br />

approaches are discussed which highlight the need for focus upon the pathophysiology<br />

<strong>of</strong> disease, the biology <strong>of</strong> the drug target and the risks that need<br />

to be considered with drug intervention.<br />

MONday<br />

Poster Sessions<br />

Regional Interest Session<br />

Roundtable Sessions<br />

Symposium Sessions<br />

Thematic Sessions<br />

Workshop Sessions<br />

149

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!